Page last updated: 2024-11-01

nimodipine and Cancer of the Thyroid

nimodipine has been researched along with Cancer of the Thyroid in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattsson, P1
Björck, G1
Remahl, S1
Bäckdahl, M1
Hamberger, B1
Hydman, J1
Svensson, M1
Biagi, BA1
Enyeart, JJ1

Other Studies

2 other studies available for nimodipine and Cancer of the Thyroid

ArticleYear
Nimodipine and microsurgery induced recovery of the vocal cord after recurrent laryngeal nerve resection.
    The Laryngoscope, 2005, Volume: 115, Issue:10

    Topics: Adenocarcinoma, Papillary; Adult; Calcium Channel Blockers; Humans; Male; Microsurgery; Nerve Regene

2005
Multiple calcium currents in a thyroid C-cell line: biophysical properties and pharmacology.
    The American journal of physiology, 1991, Volume: 260, Issue:6 Pt 1

    Topics: Animals; Barium; Calcium; Calcium Channels; Cell Line; Kinetics; Membrane Potentials; Nimodipine; om

1991